Victory Capital Management’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$37.8M Buy
219,118
+94,192
+75% +$16.3M 0.02% 650
2025
Q1
$19.5M Sell
124,926
-6,427
-5% -$1M 0.02% 819
2024
Q4
$18.1M Sell
131,353
-2,505
-2% -$345K 0.02% 886
2024
Q3
$20M Sell
133,858
-551
-0.4% -$82.3K 0.02% 847
2024
Q2
$18.3M Sell
134,409
-155
-0.1% -$21.1K 0.02% 841
2024
Q1
$20.3M Buy
+134,564
New +$20.3M 0.02% 813
2021
Q2
Sell
-518,396
Closed -$66.8M 2745
2021
Q1
$66.8M Buy
518,396
+10,638
+2% +$1.37M 0.07% 422
2020
Q4
$84.7M Buy
507,758
+142,341
+39% +$23.7M 0.09% 319
2020
Q3
$56.4M Sell
365,417
-33,021
-8% -$5.1M 0.07% 424
2020
Q2
$58.9M Sell
398,438
-404,614
-50% -$59.8M 0.08% 369
2020
Q1
$90.4M Buy
803,052
+258,087
+47% +$29.1M 0.08% 369
2019
Q4
$75.8M Buy
544,965
+106,451
+24% +$14.8M 0.09% 315
2019
Q3
$42.2M Buy
438,514
+97,606
+29% +$9.4M 0.05% 515
2019
Q2
$39.3M Buy
340,908
+18,190
+6% +$2.09M 0.08% 387
2019
Q1
$38M Buy
322,718
+299,400
+1,284% +$35.2M 0.09% 366
2018
Q4
$1.46M Sell
23,318
-420
-2% -$26.3K ﹤0.01% 1115
2018
Q3
$1.68M Sell
23,738
-1,240
-5% -$87.9K ﹤0.01% 1136
2018
Q2
$1.66M Sell
24,978
-1,360
-5% -$90.5K ﹤0.01% 1116
2018
Q1
$1.72M Buy
26,338
+8,970
+52% +$587K ﹤0.01% 1108
2017
Q4
$696K Buy
17,368
+12,010
+224% +$481K ﹤0.01% 1288
2017
Q3
$194K Buy
+5,358
New +$194K ﹤0.01% 1541
2017
Q2
Sell
-5,158
Closed -$144K 1809
2017
Q1
$144K Buy
+5,158
New +$144K ﹤0.01% 1521